Improving sponsors’ letters and documents about recalls for medicines and medical devices in Australia and reporting progress with a recall are among the five themes set out in a discussion paper published for consultation by the Therapeutic Goods Administration.
The paper on improving the therapeutic goods recall processes relates to Phase 2 of the TGA’s recall reforms program, which deals with making further revisions to the agency’s current guidance...